Vanda Pharmaceuticals

VNDANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$300.678 M

$5.00 -2.25%

Close of 7 Aug 2026

Revenue

$216.1M

#2270 by revenue

Earnings

-$220.5M

Loss-making

Shares outstanding

60,462,687

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#233Amarin Corp Plc\UkAMRN$303.3M
#234Opus GeneticsIRD$302.2M
#235Vanda PharmaceuticalsVNDA$300.7M
#236Zentalis PharmaceuticalsZNTL$300.4M
#237Fulcrum TherapeuticsFULC$296.8M

Where these numbers come from

Share counts and financials for Vanda Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.